• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[术前双膦酸盐治疗对原发性甲状旁腺功能亢进症患者甲状旁腺切除术后一年骨密度的影响]

[Effect of preoperative bisphosphonate therapy on bone mineral density in patients with primary hyperparathyroidism one year after parathyroidectomy].

作者信息

Pershina-Miliutina A P, Eremkina A K, Ozhimalov I D, Khairieva А V, Gorbacheva A M, Ronzhina S V, Mokrysheva N G

机构信息

I.I. Dedov Endocrinology Research Centre.

Lomonosov Moscow State University.

出版信息

Probl Endokrinol (Mosk). 2025 Sep 14;71(4):57-70. doi: 10.14341/probl13574.

DOI:10.14341/probl13574
PMID:41014616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12489962/
Abstract

BACKGROUND

The main treatment for primary hyperparathyroidism (PHPT) is parathyroidectomy (PTE), conservative therapy, including bisphosphonates, can be used for preoperative correction of hypercalcemia, as well as to improve bone tissue condition among individuals for whom surgery should be postponed or cannot be performed due to high perioperative risks. The question of the effect of bisphosphonates on bone tissue after surgery remains open.

AIM

To study the effect of preoperative bisphosphonate therapy on BMD parameters assessed in DXA and 3D-DXA in patients with PHPT one year after radical PTE.

MATERIALS AND METHODS

The study was conducted on the basis of the Department of pathology of the parathyroid glands and disorders of mineral metabolism of "Endocrinology Research Center" state-funded research facility of the Ministry of Health of the Russian Federation. The study included 50 patients (2 men, 48 women), divided into two groups depending on the presence or absence of preoperative bisphosphonate (BF) therapy. The methods of DXA and 3D-DXA using 3D-Shaper Medical software were used to evaluate BMD and bone microarchitectonics. The statistical analysis was performed using the R language and the Statistica v.13 package.

RESULTS

At the time of the disease's manifestation, both groups were comparable in terms of the main indicators of calcium phosphorus metabolism, with the exception of the level of beta-crosslapse, which was higher in the group without preoperative BPh therapy (p<0,001). There were also no differences in the parameters of DXA and 3D-DXA. After surgery, both groups showed a comparable increase in BMD based on the results of DXA in the main parts of the skeleton and 3D-DXA in the femur. Changes at the level of the statistical trend were obtained for the 3D-DXA parameters, the final absolute values of which were slightly higher in the second group, including the thickness of the cortical layer in the femur as a whole and in the neck. When comparing the results of DXA before and after PTE in patients receiving BPh, statistically significant differences in absolute BMD values were obtained only in the lumbar spine (p<0,001).According to 3D-DXA data, statistically significant differences were found only in the volume of mineral density of the trabecular bone of the femur as a whole (p=0,001).When analyzing up to - in the second group, statistically significant differences in absolute BMD values were observed in the lumbar region (p<0,001), in the hip as a whole (p<0,001) and in its neck (p=0,001).According to 3D-DXA data, statistically significant differences were found in three of the eight analyzed indicators, the volume of mineral density of the trabecular bone of the femur as a whole and in the neck (p<0,001 for both), as well as the volume of mineral density of the cortical bone in the neck, (p=0,001).

CONCLUSION

The 3D-DXA method allows us to evaluate not only BMD, but also its microarchitectonics, which is important for predicting the risk of fractures in patients with PHPT. Studies have shown that preoperative BPh therapy can negatively affect the recovery of BMD after PTE, especially in cortical bone tissue. Further studies are needed to confirm these data and clarify the effect of CF on the postoperative course of PHPT.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/b1e7247de22f/problendo-71-13574-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/52c86f3a070c/problendo-71-13574-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/036dcd113623/problendo-71-13574-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/29f8bb3cdb3a/problendo-71-13574-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/1a04229cd6e8/problendo-71-13574-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/32a0e1c9ca0a/problendo-71-13574-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/b1e7247de22f/problendo-71-13574-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/52c86f3a070c/problendo-71-13574-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/036dcd113623/problendo-71-13574-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/29f8bb3cdb3a/problendo-71-13574-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/1a04229cd6e8/problendo-71-13574-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/32a0e1c9ca0a/problendo-71-13574-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab4/12489962/b1e7247de22f/problendo-71-13574-g006.jpg
摘要

背景

原发性甲状旁腺功能亢进症(PHPT)的主要治疗方法是甲状旁腺切除术(PTE),保守治疗,包括双膦酸盐类药物,可用于术前纠正高钙血症,以及改善因围手术期风险高而应推迟手术或无法进行手术的患者的骨组织状况。双膦酸盐类药物对术后骨组织的影响问题仍未解决。

目的

研究术前双膦酸盐治疗对根治性PTE术后一年的PHPT患者通过双能X线吸收法(DXA)和三维双能X线吸收法(3D-DXA)评估的骨密度参数的影响。

材料与方法

该研究在俄罗斯联邦卫生部国家资助研究机构“内分泌研究中心”的甲状旁腺病理学和矿物质代谢紊乱科进行。该研究纳入了50例患者(2例男性,48例女性),根据术前是否接受双膦酸盐(BF)治疗分为两组。使用3D-Shaper Medical软件的DXA和3D-DXA方法评估骨密度和骨微结构。使用R语言和Statistica v.13软件包进行统计分析。

结果

在疾病表现时,两组在钙磷代谢的主要指标方面具有可比性,但β-交联羧基末端肽水平除外,未接受术前双膦酸盐治疗的组中该水平较高(p<0.001)。DXA和3D-DXA参数也没有差异。术后,根据DXA结果,两组在主要骨骼部位和股骨的3D-DXA结果显示骨密度有可比的增加。3D-DXA参数在统计趋势水平上有变化,第二组的最终绝对值略高,包括整个股骨和股骨颈的皮质层厚度。在接受双膦酸盐治疗的患者中比较PTE前后的DXA结果时,仅在腰椎获得了骨密度绝对值的统计学显著差异(p<0.001)。根据3D-DXA数据,仅在整个股骨小梁骨矿物质密度体积方面发现统计学显著差异(p = 0.001)。在分析第二组时,在腰椎区域(p<0.001)、整个髋部(p<0.001)及其颈部(p = 0.001)观察到骨密度绝对值的统计学显著差异。根据3D-DXA数据,在八个分析指标中的三个指标上发现统计学显著差异,即整个股骨和股骨颈的小梁骨矿物质密度体积(两者均p<0.001),以及颈部皮质骨矿物质密度体积(p = 0.001)。

结论

3D-DXA方法不仅可以评估骨密度,还可以评估其微结构,这对于预测PHPT患者的骨折风险很重要。研究表明,术前双膦酸盐治疗可能会对PTE术后骨密度的恢复产生负面影响,尤其是在皮质骨组织中。需要进一步研究来证实这些数据并阐明CF对PHPT术后病程的影响。

相似文献

1
[Effect of preoperative bisphosphonate therapy on bone mineral density in patients with primary hyperparathyroidism one year after parathyroidectomy].[术前双膦酸盐治疗对原发性甲状旁腺功能亢进症患者甲状旁腺切除术后一年骨密度的影响]
Probl Endokrinol (Mosk). 2025 Sep 14;71(4):57-70. doi: 10.14341/probl13574.
2
Vesicoureteral Reflux膀胱输尿管反流
3
Parathyroidectomy for adults with primary hyperparathyroidism.甲状旁腺切除术治疗原发性甲状旁腺功能亢进症成人患者。
Cochrane Database Syst Rev. 2023 Mar 8;3(3):CD013035. doi: 10.1002/14651858.CD013035.pub2.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Bisphosphonate therapy for osteogenesis imperfecta.用于成骨不全症的双膦酸盐治疗
Cochrane Database Syst Rev. 2016 Oct 19;10(10):CD005088. doi: 10.1002/14651858.CD005088.pub4.
6
Bisphosphonate therapy for osteogenesis imperfecta.用于成骨不全的双膦酸盐治疗
Cochrane Database Syst Rev. 2014 Jul 23(7):CD005088. doi: 10.1002/14651858.CD005088.pub3.
7
Mid Forehead Brow Lift额中眉提升术
8
Treatment for osteoporosis in people with ß-thalassaemia.β地中海贫血患者骨质疏松症的治疗
Cochrane Database Syst Rev. 2016 Mar 10;3:CD010429. doi: 10.1002/14651858.CD010429.pub2.
9
Bisphosphonates for steroid-induced osteoporosis.双膦酸盐用于治疗类固醇诱导的骨质疏松症。
Cochrane Database Syst Rev. 2016 Oct 5;10(10):CD001347. doi: 10.1002/14651858.CD001347.pub2.
10
Shoulder Arthrogram肩关节造影

本文引用的文献

1
Bone Disease in Primary Hyperparathyroidism-Changes Occurring in Bone Metabolism and New Potential Treatment Strategies.原发性甲状旁腺功能亢进症中的骨骼疾病——骨骼代谢的变化及新的潜在治疗策略。
Int J Mol Sci. 2024 Oct 30;25(21):11639. doi: 10.3390/ijms252111639.
2
Skeletal Effect of Parathyroidectomy on Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.甲状旁腺切除术对原发性甲状旁腺功能亢进症患者骨骼的影响:系统评价和荟萃分析。
J Clin Endocrinol Metab. 2024 Sep 16;109(10):e1922-e1935. doi: 10.1210/clinem/dgae326.
3
Primary Hyperparathyroidism: Assessment of the Effects of Parathyroidectomy Using Dual X-Ray Absorptiometry, Trabecular Bone Score, and Dual X-Ray Absorptiometry-Based Three-Dimensional Modeling.
原发性甲状旁腺功能亢进症:应用双能 X 射线吸收法、骨小梁评分和基于双能 X 射线吸收法的三维建模评估甲状旁腺切除术的效果。
Endocr Pract. 2024 Apr;30(4):340-347. doi: 10.1016/j.eprac.2024.01.004. Epub 2024 Jan 5.
4
The Russian registry of primary hyperparathyroidism, latest update.俄罗斯原发性甲状旁腺功能亢进症登记处,最新更新。
Front Endocrinol (Lausanne). 2023 Jul 3;14:1203437. doi: 10.3389/fendo.2023.1203437. eCollection 2023.
5
Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis.抗吸收药物双膦酸盐和地舒单抗在原发性甲状旁腺功能亢进症中缓解高钙血症和骨丢失的疗效:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Feb 2;14:1098841. doi: 10.3389/fendo.2023.1098841. eCollection 2023.
6
The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.原发性甲状旁腺功能亢进症患者的药物和手术治疗的疗效和安全性:一项随机对照试验的系统评价和荟萃分析。
J Bone Miner Res. 2022 Nov;37(11):2351-2372. doi: 10.1002/jbmr.4685. Epub 2022 Oct 17.
7
Parathyroidectomy in the elderly is beneficial and safe with similar improvements in postoperative bone mineral density.老年患者甲状旁腺切除术有益且安全,术后骨密度也有类似改善。
Am J Surg. 2022 Jul;224(1 Pt A):147-152. doi: 10.1016/j.amjsurg.2022.04.031. Epub 2022 Apr 25.
8
Skeletal effects of combined bisphosphonates treatment and parathyroidectomy in osteoporotic patients with primary hyperparathyroidism.联合双磷酸盐治疗和甲状旁腺切除术对原发性甲状旁腺功能亢进骨质疏松患者的骨骼影响。
J Bone Miner Metab. 2022 Mar;40(2):292-300. doi: 10.1007/s00774-021-01279-2. Epub 2021 Nov 10.
9
Bone Analysis Using Trabecular Bone Score and Dual-Energy X-Ray Absorptiometry-Based 3-Dimensional Modeling in Postmenopausal Women With Primary Hyperparathyroidism.绝经后原发性甲状旁腺功能亢进症患者的骨小梁骨评分和双能 X 射线吸收法三维建模的骨分析。
Endocr Pract. 2022 Jan;28(1):83-89. doi: 10.1016/j.eprac.2021.08.006. Epub 2021 Aug 25.
10
[Primary hyperparathyroidism in Russia according to the registry].[俄罗斯登记处登记的原发性甲状旁腺功能亢进症]
Probl Endokrinol (Mosk). 2019 Nov 23;65(5):300-310. doi: 10.14341/probl10126.